PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ)

CUSIP: 71426V306

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM NEW
Total 13F shares
1,971,149
Share change
+1,734,667
Total reported value
$3,824,000
Put/Call ratio
112%
Price per share
$1.94
Number of holders
22
Value change
+$3,378,447
Number of buys
22
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 71426V306?
CUSIP 71426V306 identifies PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) as of Q4 2016

As of 31 Dec 2016, PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,971,149 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, GLOBEFLEX CAPITAL L P, VANGUARD GROUP INC, Aisling Capital LLC, BlackRock Institutional Trust Company, N.A., KCG HOLDINGS, INC., OXFORD ASSET MANAGEMENT, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC. This page lists 22 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.